Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 14.19 M | $590.91 M | 0.44% | 15.13% |
| VANGUARD GROUP INC | 11/07/2025 | 9.17 M | $381.94 M | -0.93% | 9.78% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 8.38 M | $349.11 M | 44.34% | 8.94% |
| BLACKROCK, INC. | 11/12/2025 | 7.59 M | $315.98 M | 2.26% | 8.09% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 6.48 M | $269.96 M | 1.27% | 6.91% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 5.77 M | $240.32 M | 24.19% | 6.15% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 5.31 M | $221.01 M | -5.08% | 5.66% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 4.29 M | $178.60 M | 0.00% | 4.57% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 3.86 M | $160.70 M | 13.15% | 4.11% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 2.55 M | $106.24 M | 8.84% | 2.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.28 M | $94.93 M | 2.96% | 2.43% |
| STATE STREET CORP | 11/14/2025 | 2.21 M | $91.95 M | -31.53% | 2.35% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 2.04 M | $85.16 M | 2.90% | 2.18% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 2.00 M | $83.44 M | 0.26% | 2.14% |
| SIREN, L.L.C. | 11/13/2025 | 1.69 M | $70.33 M | 0.00% | 1.80% |
| NOVO HOLDINGS A/S | 11/14/2025 | 1.63 M | $67.68 M | 4.84% | 1.73% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.47 M | $61.03 M | 22.06% | 1.56% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.26 M | $52.43 M | 279.18% | 1.34% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 1.13 M | $47.21 M | 33.57% | 1.21% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.10 M | $45.77 M | -4.35% | 1.17% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 941.52 K | $39.21 M | 8.95% | 1.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 884.51 K | $36.84 M | 35.32% | 0.94% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2025 | 883.00 K | $36.78 M | -0.62% | 0.94% |
| RTW INVESTMENTS, LP | 11/14/2025 | 872.39 K | $36.33 M | 86.81% | 0.93% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 850.55 K | $35.43 M | -12.39% | 0.91% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 834.03 K | $34.74 M | 17.02% | 0.89% |
| NORTHERN TRUST CORP | 11/14/2025 | 809.89 K | $33.73 M | 3.27% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 778.65 K | $32.43 M | 1.62% | 0.83% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 758.36 K | $31.59 M | 2.89% | 0.81% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 750.00 K | $31.24 M | -50.00% | 0.80% |
| CANDRIAM S.C.A. | 11/06/2025 | 745.09 K | $31.03 M | 7.38% | 0.79% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 713.13 K | $29.70 M | -20.84% | 0.76% |
| MORGAN STANLEY | 11/14/2025 | 682.13 K | $28.41 M | -10.25% | 0.73% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 614.82 K | $25.61 M | 157.67% | 0.66% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 601.04 K | $25.03 M | 4.84% | 0.64% |
| NUVEEN, LLC | 11/12/2025 | 544.75 K | $22.69 M | 3.77% | 0.58% |
| FIERA CAPITAL CORP | 11/07/2025 | 435.43 K | $18.14 M | -2.00% | 0.46% |
| UBS GROUP AG | 11/13/2025 | 407.72 K | $16.98 M | 27.20% | 0.43% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 400.00 K | $16.66 M | 0.00% | 0.43% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 399.63 K | $16.64 M | 15.53% | 0.43% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 10/30/2025 | 387.93 K | $16.16 M | 13.53% | 0.41% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 377.80 K | $15.74 M | 115.57% | 0.40% |
| ABRDN PLC | 11/07/2025 | 339.95 K | $14.16 M | 21.26% | 0.36% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 328.68 K | $13.69 M | 10.25% | 0.35% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 295.01 K | $12.29 M | -6.51% | 0.31% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 280.00 K | $11.66 M | 0.00% | 0.30% |
| CHECKPOINT CAPITAL L.P. | 11/14/2025 | 260.00 K | $10.83 M | 100.00% | 0.28% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 257.70 K | $10.73 M | 100.00% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 257.51 K | $10.73 M | 101.71% | 0.27% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 248.37 K | $10.34 M | 367.52% | 0.26% |
Crinetics Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 288 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FMR LLC: 14.19 M
VANGUARD GROUP INC: 9.17 M
WELLINGTON MANAGEMENT GROUP LLP: 8.38 M
BlackRock, Inc.: 7.59 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 6.48 M
FARALLON CAPITAL MANAGEMENT LLC: 5.77 M
114.83% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 115.33 M shares in the last 24 months. This purchase volume represents approximately $4.71 B in transactions.